Liver Transplantation for Hepatic Adenoma
Liver transplantation for hepatic adenoma should be reserved for extremely rare circumstances: proven or highly suspected malignant transformation to hepatocellular carcinoma, unresectable tumors with uncontrolled life-threatening hemorrhage despite embolization, or hepatic adenomatosis causing liver failure. 1
Primary Indications
The most important indication is malignant transformation. In the largest European series of 49 patients transplanted for adenomatosis, the primary indications were either suspected HCC (15 patients) or histologically proven HCC (16 patients), though only 17 had actual malignant transformation 1. This highlights a critical pitfall: overestimating malignancy risk leads to unnecessary transplantation. The decision should rely on morphological imaging data combined with histological evidence of transformation, not suspicion alone 1.
Life-Threatening Hemorrhage
Uncontrolled hemorrhage from ruptured adenomas represents an emergency indication when:
- Transarterial embolization fails to control bleeding 2, 3
- Patient develops hemorrhagic shock with hemodynamic instability
- Toxic liver syndrome develops (hepatic failure, renal failure, ongoing hemorrhage) 3
In these catastrophic scenarios, hepatectomy with immediate or staged liver transplantation may be lifesaving 3. However, this represents an exceptionally rare clinical situation.
Hepatic Adenomatosis with Liver Failure
Massive adenomatosis causing liver failure through mass effect (bile duct compression, vascular compromise) constitutes another rare but legitimate indication 4. Downsizing strategies such as radioembolization may be needed as a bridge to transplantation 4.
When NOT to Transplant
The evidence strongly suggests that most hepatic adenomas should never reach transplantation. The UK NHSBT guidelines emphasize strict selection criteria and systematic work-up before even considering transplant referral 5.
Key exclusions:
- Resectable adenomas (surgery is preferred)
- Adenomas responsive to conservative management (discontinuing oral contraceptives, weight loss)
- Small asymptomatic adenomas under surveillance
- Adenomas without proven malignancy or life-threatening complications
Critical Decision Algorithm
- First, determine resectability: If resectable, surgical resection is preferred over transplantation
- If unresectable, assess for malignant transformation: Require both imaging characteristics AND histological confirmation when possible
- If hemorrhage occurs: Attempt transarterial embolization first; only proceed to transplant if embolization fails and patient develops toxic liver syndrome
- For adenomatosis: Consider transplant only if causing actual liver failure or proven malignancy
Important Caveats
Glycogen storage disease patients represent a special subgroup where adenomatosis is more common, but even here, transplantation should primarily address malignant transformation rather than adenoma presence alone 1.
Recurrence risk: Three patients with HCC on explant developed recurrence after transplantation in the European series, emphasizing that even with proven malignancy, outcomes are not guaranteed 1.
The fundamental principle: Given organ scarcity and excellent transplant outcomes for other indications (96% one-year survival for standard indications 6), hepatic adenoma should remain an extremely rare transplant indication 1. The threshold must be high: documented malignancy, uncontrollable hemorrhage with organ failure, or true liver failure from mass effect—not merely large size or theoretical risk.